Medical Finalist - NETrolyze: A Novel Immunotherapy for Triple-Negative Breast Cancer
TBMG-51930
11/01/2024
- Content
Sam Currier and Priyan Weerrappuli University of Michigan West Bloomfield, MI
- Citation
- "Medical Finalist - NETrolyze: A Novel Immunotherapy for Triple-Negative Breast Cancer," Mobility Engineering, November 1, 2024.